The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Multifaceted roles of PGE2 in inflammation and cancer
Open accessAbstract
Prostaglandin E2 (PGE2) is a bioactive lipid that elicits a wide range of biological effects associated with inflammation and cancer. PGE2 exerts diverse effects on cell proliferation, apoptosis, angiogenesis, inflammation, and immune surveillance. This review concentrates primarily on gastrointestinal cancers, where the actions of PGE2 are most prominent, most likely due to the constant exposure to dietary and environmental insults and the intrinsic role of PGE2 in tissue homeostasis. A discussion of recent efforts to elucidate the complex and interconnected pathways that link PGE2 signaling with inflammation and cancer is provided, supported by the abundant literature showing a protective effect of NSAIDs and the therapeutic efficacy of targeting mPGES-1 or EP receptors for cancer prevention. However, suppressing PGE2 formation as a means of providing chemoprotection against all cancers may not ultimately be tenable, undoubtedly the situation for patients with inflammatory bowel disease. Future studies to fully understand the complex role of PGE2 in both inflammation and cancer will be required to develop novel strategies for cancer prevention that are both effective and safe.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Gurtner, G. C., Werner, S., Barrandon, Y., & Longaker, M. T. (2008) · Nature · doi:10.1038/nature07039 · Cited by 6,542
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“As postulated by Dvorak, “tumors are wounds that never heal” [137], thus underscoring the fundamental similarities that exist between tumor development and the wound healing process [138].”
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Development, cytokine profile and function of human interleukin 17-producing helper T cells
Wilson, N. J., Boniface, K., Chan, J. R., McKenzie, B. S., Blumenschein, W. M., Mattson, J. D., Basham, B., Smith, K., Chen, T., Morel, F., et al. (2007) · Nature Immunology · doi:10.1038/ni1497 · Cited by 2,035
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Ostrand-Rosenberg, S., & Sinha, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802740 · Cited by 1,736
Coleman, R. A., Smith, W. L., & Narumiya, S. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06784-5 · Cited by 1,735
Aspirin Use and Reduced Risk of Fatal Colon Cancer
Thun, M. J., Namboodiri, M. M., & Heath, C. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252301 · Cited by 1,673
Regulation of Immune Responses by Prostaglandin E2
Kalinski, P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101029 · Cited by 1,474
Functional Specialization of Interleukin-17 Family Members
Iwakura, Y., Ishigame, H., Saijo, S., & Nakae, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.012 · Cited by 1,289
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Sugimoto, Y., & Narumiya, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r600038200 · Cited by 1,196
Intestinal Inflammation and Cancer
Ullman, T. A., & Itzkowitz, S. H. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.057 · Cited by 1,119
Prostanoid Receptors: Subtypes and Signaling
Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.661 · Cited by 1,011
Jakobsson, P.-J., Thorén, S., Morgenstern, R., & Samuelsson, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7220 · Cited by 996
Murakami, M., Naraba, H., Tanioka, T., Semmyo, N., Nakatani, Y., Kojima, F., Ikeda, T., Fueki, M., Ueno, A., Oh-ishi, S., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003505200 · Cited by 964
Cancer as an overhealing wound: an old hypothesis revisited
Schäfer, M., & Werner, S. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2455 · Cited by 956
Wang, D. (2006) · Gut · doi:10.1136/gut.2004.047100 · Cited by 899
Prostaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling Axis
Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M., & Gutkind, J. S. (2005) · Science · doi:10.1126/science.1116221 · Cited by 883
The eicosanoids and their biochemical mechanisms of action
Smith, W. L. (1989) · Biochemical Journal · doi:10.1042/bj2590315 · Cited by 871
Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines
Betz, M., & Fox, B. S. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.1.108 · Cited by 821
Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice
Liu, C. H., Chang, S.-H., Narko, K., Trifan, O. C., Wu, M.-T., Smith, E., Haudenschild, C., Lane, T. F., & Hla, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010787200 · Cited by 807
Rodriguez, P. C., Ernstoff, M. S., Hernandez, C., Atkins, M., Zabaleta, J., Sierra, R., & Ochoa, A. C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1921 · Cited by 773
Prostaglandin E2 Promotes Tumor Progression by Inducing Myeloid-Derived Suppressor Cells
Sinha, P., Clements, V. K., Fulton, A. M., & Ostrand-Rosenberg, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4174 · Cited by 755
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice
Sonoshita, M., Takaku, K., Sasaki, N., Sugimoto, Y., Ushikubi, F., Narumiya, S., Oshima, M., & Taketo, M. M. (2001) · Nature Medicine · doi:10.1038/nm0901-1048 · Cited by 587
Prostaglandin E2 Induces FOXP3 Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells
Baratelli, F., Lin, Y., Zhu, L., Yang, S.-C., Heuzé-Vourc’h, N., Zeng, G., Reckamp, K., Dohadwala, M., Sharma, S., & Dubinett, S. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1483 · Cited by 573
Membrane Prostaglandin E Synthase-1: A Novel Therapeutic Target
Samuelsson, B., Morgenstern, R., & Jakobsson, P.-J. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.3.1 · Cited by 538
Sulindac for polyposis of the colon
Waddell, W. R., & Loughry, R. W. (1983) · Journal of Surgical Oncology · doi:10.1002/jso.2930240119 · Cited by 513
Regulatory Lymphocytes and Intestinal Inflammation
Izcue, A., Coombes, J. L., & Powrie, F. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132657 · Cited by 507
Sharma, S., Yang, S.-C., Zhu, L., Reckamp, K., Gardner, B., Baratelli, F., Huang, M., Batra, R. K., & Dubinett, S. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0141 · Cited by 506
A Hypothesis: Nonsteroidal Anti-Inflammatory Drugs Reduce the Incidence of Large-Bowel Cancer
Rosenberg, L., Palmer, J. R., Zauber, A. G., Warshauer, M. E., Stolley, P. D., & Shapiro, S. (1991) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/83.5.355 · Cited by 501
Obermajer, N., Muthuswamy, R., Lesnock, J., Edwards, R. P., & Kalinski, P. (2011) · Blood · doi:10.1182/blood-2011-07-365825 · Cited by 497
Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.
Chulada, P. C., Thompson, M. B., Mahler, J. F., Doyle, C. M., Gaul, B. W., Lee, C., Tiano, H. F., Morham, S. G., Smithies, O., & Langenbach, R. J. (2000) · PubMed · Cited by 496
Boniface, K., Bak-Jensen, K. S., Li, Y., Blumenschein, W. M., McGeachy, M. J., McClanahan, T. K., McKenzie, B. S., Kastelein, R. A., Cua, D. J., & de Waal Malefyt, R. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082293 · Cited by 479
Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes
Snijdewint, F. G., Kaliński, P., Wierenga, E. A., Bos, J. D., & Kapsenberg, M. L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5321 · Cited by 477
Obermajer, N., Muthuswamy, R., Odunsi, K., Edwards, R. P., & Kalinski, P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2449 · Cited by 464
Buchanan, F. G., Wang, D., Bargiacchi, F., & DuBois, R. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302474200 · Cited by 463
Fehérvari, Z., & Sakaguchi, S. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423395 · Cited by 452
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut
Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi, E., Tsuboi, K., Sugimoto, Y., Kobayashi, T., Miyachi, Y., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214459 · Cited by 418
Sulindac for polyposis of the colon
Waddell, W. R., Ganser, G. F., Cerise, E. J., & Loughry, R. W. (1989) · The American Journal of Surgery · doi:10.1016/0002-9610(89)90442-x · Cited by 409
Inflammation and cancer: how friendly is the relationship for cancer patients?
Aggarwal, B. B., & Gehlot, P. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.020 · Cited by 405
Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.
Mutoh, M., Watanabe, K., Kitamura, T., Shoji, Y., Takahashi, M., Kawamori, T., Tani, K., Kobayashi, M., Maruyama, T., Kobayashi, K., et al. (2002) · PubMed · Cited by 362
Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis.
Watanabe, K., Kawamori, T., Nakatsugi, S., Ohta, T., Ohuchida, S., Yamamoto, H., Maruyama, T., Kondo, K., Ushikubi, F., Narumiya, S., et al. (1999) · PubMed · Cited by 351
Evolution of Th2 Immunity: A Rapid Repair Response to Tissue Destructive Pathogens
Allen, J. E., & Wynn, T. A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002003 · Cited by 338
Uematsu, S., Matsumoto, M., Takeda, K., & Akira, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5811 · Cited by 309
Herrinton, L. J., Liu, L., Levin, T. R., Allison, J. E., Lewis, J. D., & Velayos, F. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.054 · Cited by 307
15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer
Backlund, M. G., Mann, J. R., Holla, V. R., Buchanan, F. G., Tai, H.-H., Musiek, E. S., Milne, G. L., Katkuri, S., & DuBois, R. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411221200 · Cited by 301
Kolodsick, J. E., Peters-Golden, M., Larios, J., Toews, G. B., Thannickal, V. J., & Moore, B. B. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0243oc · Cited by 294
Sheibanie, A. F., Yen, J.-H., Khayrullina, T., Emig, F., Zhang, M., Tuma, R., & Ganea, D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.8138 · Cited by 284
Cyclooxygenase 2 Plays a Pivotal Role in the Resolution of Acute Lung Injury
Fukunaga, K., Kohli, P., Bonnans, C., Fredenburgh, L. E., & Levy, B. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.5033 · Cited by 275
15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis
Myung, S.-J., Rerko, R. M., Yan, M., Platzer, P., Guda, K., Dotson, A., Lawrence, E., Dannenberg, A. J., Lovgren, A. K., Luo, G., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603235103 · Cited by 264
The Anti-Inflammatory Effects of Prostaglandins
Scher, J. U., & Pillinger, M. H. (2009) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31819aaa76 · Cited by 259
Wound healing of intestinal epithelial cells
Iizuka, M. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i17.2161 · Cited by 259
Cianchi, F., Cortesini, C., Bechi, P., Fantappiè, O., Messerini, L., Vannacci, A., Sardi, I., Baroni, G., Boddi, V., Mazzanti, R., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.29691 · Cited by 255
Hyperplastic gastric tumors induced by activated macrophages in COX‐2/mPGES‐1 transgenic mice
Oshima, H., Oshima, M., Inaba, K., & Taketo, M. M. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600170 · Cited by 251
Yan, M., Rerko, R. M., Platzer, P., Dawson, D., Willis, J., Tong, M., Lawrence, E., Lutterbaugh, J., Lu, S., Willson, J. K. V., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406142101 · Cited by 243
Oshima, H., Matsunaga, A., Fujimura, T., Tsukamoto, T., Taketo, M. M., & Oshima, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.014 · Cited by 240
Wang, D., Buchanan, F. G., Wang, H., Dey, S. K., & DuBois, R. N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3671 · Cited by 193
The Role of Prostaglandins and Other Eicosanoids in the Gastrointestinal Tract
Wang, D., Mann, J. R., & Dubois, R. N. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.09.080 · Cited by 186
Enhancement of colon carcinogenesis by prostaglandin E2 administration
Kawamori, T. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg033 · Cited by 179
Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer
Guo, X., Oshima, H., & Masanobu, O. (2009) · Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) · Cited by 177
Genetic Deletion of mPGES-1 Suppresses Intestinal Tumorigenesis
Nakanishi, M., Montrose, D. C., Clark, P., Nambiar, P. R., Belinsky, G. S., Claffey, K. P., Xu, D., & Rosenberg, D. W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6100 · Cited by 167
Self-citationHowe, L. R., Chang, S.-H., Tolle, K. C., Dillon, R., Young, L. J. T., Cardiff, R. D., Newman, R. A., Yang, P., Thaler, H. T., Muller, W. J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1524 · Cited by 165
Koeberle, A., Siemoneit, U., Bühring, U., Northoff, H., Laufer, S., Albrecht, W., & Werz, O. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.139444 · Cited by 164
Mandapathil, M., Szczepanski, M. J., Szajnik, M., Ren, J., Jackson, E. K., Johnson, J. T., Gorelik, E., Lang, S., & Whiteside, T. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.127100 · Cited by 162
Prostaglandin E synthases: Understanding their pathophysiological roles through mouse genetic models
Hara, S., Kamei, D., Sasaki, Y., Tanemoto, A., Nakatani, Y., & Murakami, M. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.007 · Cited by 161
Prostaglandin E2 promotes intestinal tumor growth via DNA methylation
Xia, D., Wang, D., Kim, S.-H., Katoh, H., & DuBois, R. N. (2012) · Nature Medicine · doi:10.1038/nm.2608 · Cited by 161
Ding, Y. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh277 · Cited by 159
Yokokawa, J., Cereda, V., Remondo, C., Gulley, J. L., Arlen, P. M., Schlom, J., & Tsang, K. Y. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2056 · Cited by 155
Sheibanie, A. F., Khayrullina, T., Safadi, F. F., & Ganea, D. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22794 · Cited by 151
Yuan, X.-L., Chen, L., Li, M.-X., Dong, P., Xue, J., Wang, J., Zhang, T.-T., Wang, X.-A., Zhang, F., Ge, H.-L., et al. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.10.005 · Cited by 149
Lu, T., & Gabrilovich, D. I. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2939 · Cited by 146
Downregulation of prostaglandin E receptor subtype EP 3 during colon cancer development
Shoji, Y., Takahashi, M., Kitamura, T., Watanabe, K., Kawamori, T., Maruyama, T., Sugimoto, Y., Negishi, M., Narumiya, S., Sugimura, T., et al. (2004) · Gut · doi:10.1136/gut.2003.028787 · Cited by 145
Liu, L., Ge, D., Ma, L., Mei, J., Liu, S., Zhang, Q., Ren, F., Liao, H., Pu, Q., Wang, T., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182542752 · Cited by 144
Chell, S. D., Witherden, I. R., Dobson, R. R., Moorghen, M., Herman, A., Qualtrough, D., Williams, A. C., & Paraskeva, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3702 · Cited by 141
Rao, R., Redha, R., Macias‐Perez, I., Yan, S., Hao, C., Zent, R., Breyer, M. D., & Pozzi, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701214200 · Cited by 139
Martinet, L., Jean, C., Dietrich, G., Fournié, J., & Poupot, R. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.05.002 · Cited by 136
CANCER RISK IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Lewis, J. D., Deren, J. J., & Lichtenstein, G. R. (1999) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70065-0 · Cited by 132
PGE2 promotes angiogenesis through EP4 and PKA Cγ pathway
Zhang, Y., & Daaka, Y. (2011) · Blood · doi:10.1182/blood-2011-04-350587 · Cited by 130
Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors
Côté, B., Boulet, L., Brideau, C., Claveau, D., Ethier, D., Frenette, R., Gagnon, M., Giroux, A., Guay, J., Guiral, S., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.10.033 · Cited by 130
Prostaglandin E2, an Immunoactivator
Sakata, D., Yao, C., & Narumiya, S. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09r03cp · Cited by 128
NAD+-Linked 15-Hydroxyprostaglandin Dehydrogenase: Structure and Biological Functions
Tai, H., Cho, H., Tong, M., & Ding, Y. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776055958 · Cited by 128
Deletion of cytosolic phospholipase A 2 suppresses Apc Min -induced tumorigenesis
Hong, K. H., Bonventre, J. C., O’Leary, E., Bonventre, J. V., & Lander, E. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051635898 · Cited by 126
Colitis-associated cancer: the role of T cells in tumor development
Waldner, M. J., & Neurath, M. F. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0161-8 · Cited by 125
Prostaglandin E2 Suppresses NK Activity In Vivo and Promotes Postoperative Tumor Metastasis in Rats
Yakar, I., Melamed, R., Shakhar, G., Shakhar, K., Rosenne, E., Abudarham, N., Page, G. G., & Ben‐Eliyahu, S. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.08.017 · Cited by 124
COX-2 and PGE2-dependent immunomodulation in breast cancer
Chen, E. P., & Smyth, E. M. (2011) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2011.08.005 · Cited by 124
PROSTAGLANDIAN BIOLOGY IN INFLAMMATORY BOWEL DISEASE
Wallace, J. L. (2001) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70223-5 · Cited by 124
Koeberle, A., Northoff, H., & Werz, O. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0290 · Cited by 122
Soontrapa, K., Honda, T., Sakata, D., Yao, C., Hirata, T., Hori, S., Matsuoka, T., Kita, Y., Shimizu, T., Kabashima, K., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018625108 · Cited by 121
Muthuswamy, R., Mueller-Berghaus, J., Haberkorn, U., Reinhart, T. A., Schadendorf, D., & Kaliński, P. (2010) · Blood · doi:10.1182/blood-2009-12-258038 · Cited by 117
Coxibs and Other Nonsteroidal Anti-Inflammatory Drugs in Animal Models of Cancer Chemoprevention
Fischer, S. M., Hawk, E. T., & Lubet, R. A. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0166 · Cited by 113
Sung, Y. M., He, G., & Fischer, S. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1015 · Cited by 110
Παπανικολάου, Α., Wang, Q. S., Papanikolaou, D., Whiteley, H. E., & Rosenberg, D. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.567 · Cited by 104
Self-citationYan, M., Myung, S., Fink, S. P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902367106 · Cited by 102
Identification and Development of Mpges-1 Inhibitors: Where We are At?
Chang, H. H., & Meuillet, E. J. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.136 · Cited by 99
COX-2: A Pivotal Enzyme in Mucosal Protection and Resolution of Inflammation
Wallace, J. L. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.122 · Cited by 96
Joshi, P. C., Zhou, X., Cuchens, M. A., & Jones, Q. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.885 · Cited by 94
Selective PGE2 Suppression Inhibits Colon Carcinogenesis and Modifies Local Mucosal Immunity
Nakanishi, M., Ménoret, A., Tanaka, T., Miyamoto, S., Montrose, D. C., Vella, A. T., & Rosenberg, D. W. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0188 · Cited by 88
Self-citationMyrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E2 synthase‐1
Koeberle, A., Pollastro, F., Northoff, H., & Werz, O. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00070.x · Cited by 84
Lee, S. Y., Choi, H. K., Lee, K. J., Jung, J. Y., Hur, G. Y., Jung, K. H., Kim, J. H., Shin, C., Shim, J. J., In, K. H., et al. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31818ac2f7 · Cited by 81
Cytoplasmic Phospholipase A2 Deletion Enhances Colon Tumorigenesis
Ilsley, J. N. M., Nakanishi, M., Flynn, C. M., Belinsky, G. S., Guise, S. D., Adib, J. N., Dobrowsky, R. T., Bonventre, J. V., & Rosenberg, D. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3446 · Cited by 75
Self-citationHuman Colonic Myofibroblasts Promote Expansion of CD4+ CD25high Foxp3+ Regulatory T Cells
Pinchuk, I. V., Beswick, E. J., Saada, J. I., Boya, G., Schmitt, D. A., Raju, G. S., Brenmoehl, J., Rogler, G., Reyes, V. E., & Powell, D. W. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.059 · Cited by 72
Amano, H., Ito, Y., Suzuki, T., Kato, S., Matsui, Y., Ogawa, F., Murata, T., Sugimoto, Y., Senior, R. M., Kitasato, H., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01322.x · Cited by 71
Microsomal prostaglandin E synthase-1 is involved in multiple steps of colon carcinogenesis
Sasaki, Y., Kamei, D., Ishikawa, Y., Ishii, T., Uematsu, S., Akira, S., Murakami, M., & Hara, S. (2011) · Oncogene · doi:10.1038/onc.2011.472 · Cited by 71
Ishikawa, T., & Herschman, H. R. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq002 · Cited by 71
Proneoplastic effects of PGE2mediated by EP4 receptor in colorectal cancer
Doherty, G. A., Byrne, S. M., Molloy, E. S., Malhotra, V., Austin, S. C., Kay, E. W., Murray, F. E., & Fitzgerald, D. J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-207 · Cited by 69
Linnemeyer, P. A., & Pollack, S. B. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.9.3747 · Cited by 67
Kojima, F., Kapoor, M., Yang, L., Fleishaker, E. L., Ward, M. R., Monrad, S. U., Kottangada, P. C., Pace, C. Q., Clark, J. A., Woodward, J. G., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.8361 · Cited by 64
Giroux, A., Boulet, L., Brideau, C., Chau, A., Claveau, D., Côté, B., Ethier, D., Frenette, R., Gagnon, M., Guay, J., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.085 · Cited by 63
Microsomal prostaglandin E synthase‐1 inhibition in cardiovascular inflammatory disease
Wang, M., Song, W., Cheng, Y., & FitzGerald, G. A. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01938.x · Cited by 60
Backlund, M. G., Mann, J. R., Holla, V. R., Shi, Q., Daikoku, T., Dey, S. K., & DuBois, R. N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2893 · Cited by 60
Regulating the immune response to tumours
Betts, G. J., Clarke, S. L., Richards, H. E., Godkin, A. J., & Gallimore, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.05.006 · Cited by 57
Cytoplasmic Phospholipase A2 Levels Correlate with Apoptosis in Human Colon Tumorigenesis
Dong, M., Johnson, M., Rezaie, A., Ilsley, J. N. M., Nakanishi, M., Sanders, M. M., Forouhar, F., Levine, J. B., Montrose, D. C., Giardina, C. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1079 · Cited by 55
Self-citationProstaglandin E 2 , Wnt, and BMP in gastric tumor mouse models
Oshima, H., Oguma, K., Du, Y., & Oshima, M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01258.x · Cited by 54
Yin, H., Cheng, L., Langenbach, R. J., & Ju, C. (2006) · Hepatology · doi:10.1002/hep.21493 · Cited by 54
Chandramouli, A., Onyeagucha, B. C., Mercado-Pimentel, M. E., Stankova, L., Shahin, N. A., LaFleur, B., Heimark, R. L., Bhattacharyya, A. K., & Nelson, M. A. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.13.3.18874 · Cited by 53
Prostaglandin E2 As an Inhibitory Modulator of Fibrogenesis in Human Lung Allografts
Walker, N., Badri, L. N., Wadhwa, A., Wettlaufer, S. H., Peters-Golden, M. L., & Lama, V. N. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201105-0834oc · Cited by 52
Green tea epigallocatechin-3-gallate inhibits microsomal prostaglandin E2 synthase-1
Koeberle, A., Bauer, J., Verhoff, M., Hoffmann, M., Northoff, H., & Werz, O. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.005 · Cited by 50
Harding, P., & LaPointe, M. C. (2011) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2011.01.003 · Cited by 49
Zhu, Z., Fu, C., Li, X., Song, Y., Li, C., Zou, M., Guan, Y., & Zhu, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023554 · Cited by 48
Markosyan, N., Chen, E. P., Ndong, V. N., Yao, Y., Sterner, C. J., Chodosh, L. A., Lawson, J. A., FitzGerald, G. A., & Smyth, E. M. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr134 · Cited by 47
Chini, M. G., Simone, R. D., Bruno, I., Riccio, R., Dehm, F., Weinigel, C., Barz, D., Werz, O., & Bifulco, G. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.05.014 · Cited by 43
Genetic deletion of mPGES-1 accelerates intestinal tumorigenesis in APCMin/+ mice
Elander, N., Ungerbäck, J., Olsson, H., Uematsu, S., Akira, S., & Söderkvist, P. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.026 · Cited by 42
JIMÉNEZ, P., Piazuelo, E., Cebrián, C., Ortego, J., Strunk, M. H. P., García-González, M. A., Santander, S., Alcedo, J., & Lanas, Á. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04172.x · Cited by 38
Iwanaga, K., Okada, M., Murata, T., Hori, M., & Ozaki, H. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.189845 · Cited by 37
Dimethylcelecoxib inhibits mPGES-1 promoter activity by influencing EGR1 and NF-κB
Deckmann, K., Rörsch, F., Steri, R., Schubert‐Zsilavecz, M., Geißlinger, G., & Grösch, S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.032 · Cited by 34
Itadani, H., Oshima, H., Oshima, M., & Kotani, H. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-615 · Cited by 34
Li, Y., Yin, S., Nie, D., Xie, S., Ma, L., Wang, X., Wu, Y., & Xiao, J. (2011) · International Journal of Hematology · doi:10.1007/s12185-011-0954-0 · Cited by 28
The effect of exogenous prostaglandin administration on tumor size and yield in Min/+ mice.
Wilson, J. W., & Potten, C. S. (2000) · PubMed · Cited by 28
mPGES-1 null mice are resistant to bleomycin-induced skin fibrosis
McCann, M. R., Monemdjou, R., Ghassemi-Kakroodi, P., Fahmi, H., Pérez, G., Liu, S., Shiwen, X., Parapuram, S. K., Kojima, F., Denton, C. P., et al. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3226 · Cited by 27
Ae, T., Ohno, T., Hattori, Y., Suzuki, T., Hosono, K., Minamino, T., Sato, T., Uematsu, S., Akira, S., Koizumi, W., et al. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00013.2010 · Cited by 26
Nakanishi, M., Sato, T., Li, Y., Nelson, A. J., Farid, M., Michalski, J., Kanaji, N., Wang, X., Basma, H., Patil, A., et al. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0115oc · Cited by 24
Self-citationBeales, I., & Ogunwobi, O. O. (2009) · International Journal of Cancer · doi:10.1002/ijc.24875 · Cited by 23
Deckmann, K., Rörsch, F., Geißlinger, G., & Grösch, S. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.09.025 · Cited by 20
Physiological and pathological role of local and immigrating colonic stem cells
Sípos, F., Valcz, G., & Molnár, B. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i4.295 · Cited by 15
Ayabe, S., Murata, T., Maruyama, T., Hori, M., & Ozaki, H. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00051.x · Cited by 13
Cited by
Zou, W., Wolchok, J. D., & Chen, L. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad7118 · Cited by 2,400
Lipid metabolic reprogramming in cancer cells
Beloribi-Djefaflia, S., Vasseur, S., & Guillaumond, F. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.49 · Cited by 1,398
Tumour-associated neutrophils in patients with cancer
Shaul, M. E., & Fridlender, Z. G. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0222-4 · Cited by 1,023
Mechanisms regulating T-cell infiltration and activity in solid tumors
Lanitis, E., Dangaj, D., Irving, M., & Coukos, G. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx238 · Cited by 369
Xu, X. R., Yousef, G. M., & Ni, H. (2018) · Blood · doi:10.1182/blood-2017-05-743187 · Cited by 325
Metadata
- Authors
- Nakanishi, M., & Rosenberg, D. W.
- Venue
- Seminars in Immunopathology
- Published
- 2012-09-21
- Volume
- 35
- Issue
- 2
- Pages
- 123-137
- ISSN
- 1863-2297 (ISSN-L)
- 1863-2300
- OpenAlex
- W1988564036
- Cited by
- 591
- References
- 140
- FWCI
- 11.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.